openPR Logo
Press release

Radiopharmaceutical Market 2018 by Top Leading Vendors Life Sciences Ltd., Siemens AG, Sun Pharmaceutical Industries Ltd., Bayer AG, Cardinal Health Inc., Medtronic etc. Outlook 2023

06-11-2018 11:03 AM CET | Health & Medicine

Press release from: Market Research (MRFR) Future Reports

Radiopharmaceutical Market 2018 by Top Leading Vendors Life

Radiopharmaceutical Market Information: Type (Diagnostic Type, Therapeutic Type), Type of Test (Myocardial Perfusion Scan, Lung Scan, Others), Application (Oncology, Cardiology, Others), Route of Administration, End-User– Global Forecast (2017-2023)

The global radiopharmaceutical market is expected to grow at a CAGR of 8.7% during the forecast period 2017–2023.

KEY PLAYERS FOR RADIOPHARMACEUTICAL MARKET                       

Life Sciences Ltd., Siemens AG, Sun Pharmaceutical Industries Ltd., Bayer AG, Cardinal Health Inc., Medtronic, General Electric Company (GE Healthcare), Lantheus Medical Imaging, Inc., Advanced Accelerator Applications S.A., Mallinckrodt Pharmaceuticals, Nordion, Inc., Canadian Nuclear Laboratories (CNL), Bracco Diagnostic Inc., IBA Dosimetry GmbH, Avid Radiopharmaceuticals and few others.

Get Sample Report @ www.marketresearchfuture.com/sample_request/1650 .

MARKET HIGHLIGHTS FOR RADIOPHARMACEUTICAL MARKET            

As the healthcare industry is moving towards the personalized approaches, the role of radiopharmaceutical is also increasing. The radiopharmaceutical is acting as an all-rounder radiopharmaceutical from diagnosis to treatment for various chronic diseases such as cancers and other neurological disorders, which has provided an impetus to the market. Demand for radiopharmaceuticals is growing due to raising awareness about the availability of radiation and radioisotopes in medicine, particularly for diagnosis and therapy for various chronic conditions. In developed countries about one person in 50 uses diagnostic nuclear medicine every year, and the demand for therapy with radioisotopes is about one-tenth of this. Radiopharmaceuticals use radiation to provide diagnostic information about the functioning of a person's specific organs while radiotherapy can be used to treat some medical conditions, especially cancer, used to weaken or destroy particular targeted cells. 

The market’s growth is mainly attributed to the increasing prevalence of chronic diseases, which is creating a greater need for early diagnosis and treatment modules. Moreover, rising expenditure in oncology and growing emphasis on cancer management has also accelerated the market growth. However, the high cost of the device and low feasibility of treatment is undermining the potentials of the market to some extent. The risks associated with the use of radiopharmaceuticals also acts as a growth barrier for the market.

COMPETITIVE ANALYSIS FOR RADIOPHARMACEUTICAL MARKET

The market for Radio Pharmaceutical is characterized by the presence of several well-established and small players, the global market of Mobile Health appears to be highly competitive and fragmented. Major players are increasingly expanding their footprint in the emerging nations, making it putting pressure on the regional players, especially in terms of features such as type, product portfolios, and pricing. The market is witnessing intensified competition which is expected to get more intensified further during the forecast period. The market is witnessing intensified competition which is expected to get more intensified further during the forecast period. The global radiopharmaceutical market is experiencing extreme competition due to major companies are focusing on the development of new and advances drugs for diagnosis and treatment of various chronic diseases.

For instance, in January 2018, the company received U.S. Food and Drug Administration (FDA) approval of its new drug application (NDA) for LUTATHERA used for the treatment of somatostatin receptor positive gastroenteropancreatic neuroendocrine tumors.

In October 2017, the company announced the acquisition of SurgVision, a high-tech start-up developing a real-time Fluorescence Image Guided Surgery platform, to address an unmet medical need for oncology patients requiring tumor removal surgery.

Moreover, in January 2018, the company entered a partnership with F. Hoffmann-La Roche Ltd to develop integrated digital diagnostics platform to improve oncology and critical care treatment to accelerate and improve individualized treatment options for cancer and critical care patients.

In November 2017, the company entered into an agreement with Bruce Power to secure the long-term supply of Cobalt-60 for medical and other applications through the life of the four Bruce B reactors.

While in September 2017, The U.S. Department of Energy’s National Nuclear Security Administration (DOE/NNSA) and NTP completed conversion of medical isotope molybdenum-99 (Mo-99) production process from highly enriched uranium (HEU) to low enriched uranium (LEU) in August.

Therefore, new product launches, acquisitions and agreements are some major strategies which has adopted by the global radiopharmaceuticals to upsurge the growth of the market.

Get Discount @ www.marketresearchfuture.com/check-discount/1650 .

TOP 5 REASONS TO GET THIS REPORT

Company profiling with detailed strategies, financials, and recent development activities
Market Strategic Business Influence Data
Market Research Future recommendations in key business segments based on the market estimations
Market share analysis of the top industry players
Market forecasts for a minimum of 5 years of all the mentioned segments, Trends and the regional markets With SWOT Analysis

MAJOR TOC FOR RADIOPHARMACEUTICAL MARKET RESEARCH REPORT – FORECAST TO 2023

CHAPTER 1. REPORT PROLOGUE

CHAPTER 2. EXECUTIVE SUMMARY

CHAPTER 3.MARKET INTRODUCTION

CHAPTER 4. RESEARCH METHODOLOGY

CHAPTER 5. MARKET DYNAMICS

CHAPTER 6. MARKET FACTOR ANALYSIS

LIST OF TABLES

TABLE 1 MARKET SYNOPSIS

TABLE 2 GLOBAL RADIOPHARMACEUTICAL MARKET, BY TYPE, 2014–2023 (USD MILLION)

TABLE 3 GLOBAL RADIOPHARMACEUTICAL MARKET FOR DIAGNOSTIC, BY TYPE, 2014–2023 (USD MILLION)

TABLE 4 GLOBAL RADIOPHARMACEUTICAL MARKET FOR SPECT RADIOPHARMACEUTICALS, BY TYPE, 2014–2023 (USD MILLION)

LIST OF FIGURE

FIGURE 1 GLOBAL RADIOPHARMACEUTICAL MARKET: MARKET STRUCTURE

FIGURE 2 TOP-DOWN & BOTTOM-UP APPROACH

FIGURE 3 DRIVERS & RESTRAINTS: GLOBAL RADIOPHARMACEUTICAL MARKET

FIGURE 4 PORTERS FIVE FORCES MODEL

FIGURE 5 VALUE CHAIN: RADIOPHARMACEUTICAL MARKET

Ask to Expert Inquire @ www.marketresearchfuture.com/enquiry/1650 .

About Us:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future, Office No. 528,
Amanora Chambers Magarpatta Road,
Hadapsar, Pune - 411028 Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Radiopharmaceutical Market 2018 by Top Leading Vendors Life Sciences Ltd., Siemens AG, Sun Pharmaceutical Industries Ltd., Bayer AG, Cardinal Health Inc., Medtronic etc. Outlook 2023 here

News-ID: 1077024 • Views: 533

More Releases from Market Research (MRFR) Future Reports

Licensed Sports Merchandise Market Size, Trends, Revenue Growth, Forecast 2023: …
Implementation of effective sports marketing helps in achieving financial success of sports clubs and organizations. Major market players are focusing on analyzing the purchasing behavior of the sports fans across the globe and strategizing product launches accordingly. Events such as FIFA World Cup and National Football League (NFL) are expected to create an attraction among sports lovers which in turn will boost the inclination towards purchasing licensed sports merchandise market
Armored Vehicle Market Size | Global Industry Share and Trends Report 2019-2023
Infantry Fighting Vehicle (IFV) Market: Information by Type (Wheeled and Tracked), by Configuration (Amphibious and Non-Amphibious), by Application (Combat, Armored Reconnaissance, and Ambulance & Others), and by Region — Global Forecast till 2023 Market Highlights: The global infantry fighting vehicle market has been segmented based on type, configuration, application and region. Based on type, the infantry fighting vehicle market is divided into wheeled and tracked. The tracked segment accounted for the largest market
Digital Therapeutics Market Grooming Rapidly by Rising Trends, Technological Adv …
Digital Therapeutics Market Grow with collaborations between digital therapeutics and pharma companies is motivating the market’s development. Market reports associated with the healthcare industry have been made available by Market Research Future which creates reports on other industry verticals that outlines the current market scenarios. The market is anticipated to develop at a rapid CAGR in the forecast period. As the market is in its initial stages of growth, there is
Global Healthcare Chatbots Market Growing Opportunity, Technology and Trend Anal …
Global Healthcare Chatbots Market is set to witness healthy growth in the forthcoming years. The integration of Artificial Intelligence (AI) in the healthcare sector has paved the way for the adoption of chatbots. Additionally, healthcare chatbots are poised to handle complex tasks such as personal monitoring, appointment booking, etc. in an efficient manner and maximize the productivity of the organization. This, in turn, is expected to propel the expansion of

All 5 Releases


More Releases for RADIOPHARMACEUTICAL

A Comprehensive Study exploring Radiopharmaceutical Market | Bayer, Triad Isotop …
A latest survey on Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Radiopharmaceutical Market is conducted covering various organizations of the industry from different geographies to come up with 100+ page report. The study is a perfect mix of qualitative and quantitative information highlighting key market developments, challenges that industry and competition is facing along with gap analysis and new opportunity available and may trend in
Radiopharmaceutical Devices Global Industry Report - History, Present and Future …
The global market size of Radiopharmaceutical Devices is $XX million in 2017 with XX CAGR from 2013 to 2017, and it is expected to reach $XX million by the end of 2023 with a CAGR of XX% from 2018 to 2023. There are 3 key segments covered in this report: geography segment, end use/application segment and competitor segment. For geography segment, regional supply, application-wise and type-wise demand, major players, price is presented
Global Radiopharmaceutical Market Analysis and Forecast Predictions
The market for Radiopharmaceutical Market growing with the expansion of this Industry Sector Worldwide. Market Research Report Search Engine (MRRSE) has added a new report titled “Radiopharmaceutical Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 – 2024”which offer details about the current trends as well as scope for the near future. This research study also covers information about the production and market share based on different
Radiopharmaceutical Market | Analysis & Key Trends 2024
Radiopharmaceutical Market: Snapshot The global market for radiopharmaceuticals is poised for steady growth in the coming years, driven primarily by the rising use of radioisotopes for the treatment of various diseases, such as cancer, bone palliation, neurological disorders, and cardiovascular diseases. Around 35 million patients undergo treatment procedures for these diseases each year and this will continue to boost the demand for radiopharmaceuticals. According to the Nuclear Energy Institute, radioisotopes are essential
Radiopharmaceutical Market: Market and Growth Analysis 2024
Radiopharmaceutical Market: Snapshot The global market for radiopharmaceuticals is poised for steady growth in the coming years, driven primarily by the rising use of radioisotopes for the treatment of various diseases, such as cancer, bone palliation, neurological disorders, and cardiovascular diseases. Around 35 million patients undergo treatment procedures for these diseases each year and this will continue to boost the demand for radiopharmaceuticals. According to the Nuclear Energy Institute, radioisotopes are essential
Radiopharmaceutical Market Development Status and Outlook 2024
Radiopharmaceutical Market: Snapshot The global market for radiopharmaceuticals is poised for steady growth in the coming years, driven primarily by the rising use of radioisotopes for the treatment of various diseases, such as cancer, bone palliation, neurological disorders, and cardiovascular diseases. Around 35 million patients undergo treatment procedures for these diseases each year and this will continue to boost the demand for radiopharmaceuticals. Read Report Overview for Radiopharmaceutical Market: http://www.transparencymarketresearch.com/radiopharmaceuticals-market.html According to the